-
DE
Protease inhibition refers to the targeted blocking of proteases – enzymes that cleave proteins. It plays a central role in medicine and pharmacology.
Protease inhibition refers to the targeted blocking of proteases – enzymes that cleave proteins. It plays a central role in medicine and pharmacology.
Protease inhibition refers to the targeted blocking or suppression of proteases – a class of enzymes capable of breaking down or modifying proteins by cleaving their peptide bonds. Proteases are found in virtually all living organisms and perform essential functions including protein digestion, blood coagulation, immune defense, and cell signaling. Targeted inhibition of these enzymes can be therapeutically valuable when proteases play a key role in disease processes.
Substances that inhibit proteases are called protease inhibitors. They work by binding to the active site or another region of the protease, thereby blocking its catalytic activity. There are several mechanisms:
Protease inhibition has broad applications in modern medicine. Protease inhibitors are used across multiple therapeutic areas:
In the treatment of viral diseases such as HIV and Hepatitis C, protease inhibitors play a central role. Viruses use proteases to cleave their precursor proteins into functional components. By inhibiting these viral proteases, viral replication is effectively blocked. Well-known HIV protease inhibitors include Ritonavir, Lopinavir, and Darunavir.
Cancer cells use proteases to invade surrounding tissue and form metastases. Protease inhibitors such as Bortezomib (a proteasome inhibitor) are used in the treatment of cancers like multiple myeloma. The proteasome is a cellular protein complex that degrades damaged or unnecessary proteins; its inhibition leads to an accumulation of abnormal proteins and triggers cell death in tumor cells.
So-called DPP-4 inhibitors (gliptins) inhibit the enzyme dipeptidyl peptidase-4 (DPP-4), a protease that breaks down the blood glucose-lowering hormone GLP-1. By inhibiting DPP-4, GLP-1 remains active longer and regulates blood glucose more effectively. Examples include Sitagliptin and Saxagliptin.
During inflammatory processes, numerous proteases are released that can damage tissue. Inhibiting proteases such as elastase or cathepsins can help reduce inflammatory reactions, for example in chronic obstructive pulmonary disease (COPD) or rheumatoid arthritis.
Protease inhibition also plays a role in anticoagulation therapy. Direct oral anticoagulants (DOACs) such as Dabigatran (a thrombin inhibitor) and Rivaroxaban (a factor Xa inhibitor) act by selectively inhibiting serine proteases in the coagulation cascade, and are used to prevent stroke and thrombosis.
In addition to synthetic drugs, natural protease inhibitors also exist. Plants produce them as a defense mechanism against predators and pathogens. The human body also contains endogenous protease inhibitors, such as alpha-1-antitrypsin, which inhibits elastase in the lungs. A deficiency in alpha-1-antitrypsin can lead to pulmonary emphysema and liver damage.
Since proteases perform diverse functions in the body, their inhibition can also produce unwanted effects. Common side effects of protease inhibitors (depending on the substance class) include:
The selection and dosing of protease inhibitors should therefore always be carried out by qualified medical professionals.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.